Pharmaceutical companies in the EU have warned of a “risk of exodus” to the US as stocks in the sector slid around the world on the back of Donald Trump’s renewed threat to impose tariffs on US drugs imports. Drugmakers’ shares across Europe and India, another foreign drugs hub, slipped on Wednesday after Trump indicated further carnage was on the way in addition to the 20% “reciprocal tariffs” on imports that kicked in overnight. A basket of European healthcare stocks fell 3.9% after opening to its lowest since October 2022, leading losses among sectoral indices on the region-wide Stoxx 600
Signing of Trade Agreement Between EU, Mercosur Postponed Until January – Reports
...
Read moreDetails.jpg?width=1200&auto=webp&trim=0%2C175%2C0%2C175&ssl=1 "Historic bridge over Mississippi River set for explosive demolition")
